NCT06517706 Brain Research and Integrative Neuroscience Network for COVID-19
| NCT ID | NCT06517706 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Cyprus |
| Condition | Cognitive Training |
| Study Type | INTERVENTIONAL |
| Enrollment | 70 participants |
| Start Date | 2024-11-15 |
| Primary Completion | 2025-10-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 70 participants in total. It began in 2024-11-15 with a primary completion date of 2025-10-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of the experimental study is to investigate two interventions for the management of cognitive symptoms resulting from long COVID. Participants will be randomly assigned into two interventions. 1. Categorization Program (CP) training with active tDCS or 2. Categorization Program training with sham tDCS.
Eligibility Criteria
Inclusion Criteria: * Reported cognitive difficulties due to COVID-19 infection * WHO Long COVID criteria will be used Exclusion Criteria: * Significant history of neuropsychiatric conditions prior to contracting COVID-19; history of neurological conditions such as TBI, CVA, MS prior to contracting COVID-19.
Contact & Investigator
Fofi Constantinidou, Ph.D.
PRINCIPAL INVESTIGATOR
University of Cyprus
Frequently Asked Questions
Who can join the NCT06517706 clinical trial?
This trial is open to female participants only, aged 25 Years or older, up to 60 Years, studying Cognitive Training. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06517706 currently recruiting?
Yes, NCT06517706 is actively recruiting participants. Contact the research team at fofic@ucy.ac.cy for enrollment information.
Where is the NCT06517706 trial being conducted?
This trial is being conducted at Nicosia, Cyprus.
Who is sponsoring the NCT06517706 clinical trial?
NCT06517706 is sponsored by University of Cyprus. The principal investigator is Fofi Constantinidou, Ph.D. at University of Cyprus. The trial plans to enroll 70 participants.